DNA share

DNA listed its shares on Nasdaq Helsinki (the Helsinki Stock Exchange) towards the end of 2016. DNA’s shares were delisted from Nasdaq Helsinki on 3 February 2020.

DNA’s Initial Public Offering was arranged on 15–24 November 2016

DNA Plc listed its shares on the official list of Nasdaq Helsinki Ltd (“Helsinki Stock Exchange”).

In the IPO, shares are offered to private individuals and entities in Finland, permanent or fixed-term employees of DNA or its subsidiaries in Finland and all agency employees who work at DNA during the subscription period, the members of the Board of Directors and the CEO of DNA, and institutional investors both in Finland and internationally. 

Important dates

  • 15 November 2016 The subscription period of the IPO begins
  • 24 November 2016 The subscription period of the Public and Personnel Offering ends 
  • 29 November 2016 Press release on the final result of the IPO
  • 30 November 2016 Trading with the shares begins on the prelist of the Helsinki Stock Exchange, excluding the personnel shares
  • 2 December 2016 Trading with the shares begins on the official list of the Helsinki Stock Exchange

Materials

Press and stock exchange releases during IPO